Furthermore, AML can express molecules that trigger the downregulation of activating receptors and upregulation of ligands for inhibitory receptors or checkpoint molecules such as PD-1 and TIM3 [59,97,98,99]. Here, HAVCR2 is linked to acute myeloid leukemia.